Summary
Overview
Work History
Education
Skills
Publications
Timeline
Generic
Dr Alan Touch

Dr Alan Touch

Raleigh,NC

Summary

Curriculum Vitae Summary Name: Dr Alan Touch Email: drajtouch@gmail.com Cell: +1 919 601 0374 Current location: Raleigh, NC Education: Doctor of Optometry (OD) from Indiana University Bachelor of Arts in Psychology from the University of Iowa.

SME Hands-On Leadership Expertise: Early Stage/Mid-Size Regulatory/Clinical Development Strategic Milestone Roadmap Therapeutic Program Management & Quality Management Leadership IVD and Diagnostics Project Management and Strategic regulatory leadership Mult-pharma/Device Project Management and Strategic Regulatory Leadership Regulatory Experience including Compliance/Remediation for QMS and Technical Files.

Regulatory Medical Writing for submissions and compliance reporting Clinical Quality Management Planning and implementation Specialized leadership in developing the Strategic Regulatory and Clinical Trial Roadmap. Complete integration with the Business Model for the early stage and mid-sized healthcare companies. Global Regulatory/Clinical Development SME, Medical Device, MDR/IVDR, targeted pharma and IVD diagnostics/combination products, targeted pharma and medical device US FDA submissions and compliance. Small Molecule CDMO Chief Science Officer. Functional Clinical Development and St SME for Ophthalmology, Neurodegenerative Disease, Oncology Radiation Therapy, and Dermatology. Multiple Therapeutic areas clinical and regulatory for pharma and medical devices. Thirty years of strategic product development, regulatory leadership and hands-on experience leading teams for Sponsors and CROs in medical device, pharma and IVD/diagnostics (including combination products), medical device product development management, global regulatory affairs management, regulatory medical writing, pharma and device clinical trial design and protocol development, drug development biomarker tool models, select global therapeutic pharma clinical trials, specialized IVD clinical trial models and budgets, and clinical quality management planning including clinical GCP/ GLP compliance and audits and CAPA or other remediation. CER/PER medical writing including PMSR PMCFP/R. Senior Advisor with success boosting productivity and streamlining procedures for organizations. Focused on smoothly overseeing financial, personnel and operational facets. Expertly balanced RoadMap targets planning resources and milestone-optimized long-term success. Determined as Advisor with success in boosting productivity and streamlining procedures for organizations. Focused on smoothly overseeing financial, personnel and operational facets. Expertly balanced targets with resources and optimized long-term success. a Determined [Job Title] with success boosting productivity and streamlining procedures for organizations. Focused on smoothly overseeing financial, personnel and operational facets. Expertly balanced targets with resources and optimized long-term success. Successful [AreA of expertise] business professional with demonstrated track record consulting. Exceptional program, team and project manager. Skilled at mentoring staff, integrating ideas and customizing approaches to support specific means and goals. Reliable business professional with experience in project management, process improvement and financial analysis. Proven track record of successfully streamlining business operations and reducing costs. Adept at analyzing data to identify trends and developing strategies to improve efficiency. Forward-thinking Operations Specialist bringing [Number] years of expertise in [AreA of expertise] for [Industry] sector businesses. Cultivates rapport with individuals to optimize project goals and output, resolve complex problems and deliver innovative improvement strategies. Proficient in [SoftwAre] and [SoftwAre]. Detail-oriented team player with strong organizational skills. Ability to handle multiple projects simultaneously with a high degree of accuracy. Organized and dependable candidate successful at managing multiple priorities with a positive attitude. Willingness to take on added responsibilities to meet team goals.

Overview

24
24
years of professional experience

Work History

Principal & Senior Consulting SME

624Advisors
01.2024 - Current
  • Clients in 2024 include TAE Life Sciences (Oncology combination product) and Novo Nordisk (Device/Drug as Medical Device Combination Product Device Regulatory SME), Global Regulatory Affairs/Clinical Trial Roadmap Development, QMS, Compliance and document development SME.
  • Established and maintained relationships with key stakeholders for growth opportunities and successful partnerships.
  • Regulatory Value Proposition Roadmap Development


624Advisors Founder, Principal Senior SME

624Advisors/Avodex Partners
05.2013 - Current
  • B to B or W-2
  • 624Advisors is an ongoing consultancy through which clients access Subject Matter Expertise and Strategic Advisory for the intersection of Product Development, Regulatory Strategie,s and Clinical Development and Implementation delivered as hands-on day-to-day needs
  • Client experience over this period is, for the most part, consolidated as a seamless continuation of the mission of Avodex Partners with expanded service offerings as a partner where clients choose from a targeted menu of specialized regulatory and quality regulatory/clinical and compliance resources for specific targeted projects or backfill staffing as well as
  • Center for Strategic Regulatory and Clinical Trial Stakeholder Roadmap Development
  • Projects and Contracts have included Senior Global Strategic and Operational (hands-on) Regulatory, Product Development, Clinical Development and Compliance Consulting for Targeted Pharma Therapeutics, Medical Devices, and Diagnostics and Combination Drug-Device Products
  • This includes Ophthalmology, Oncology, Neurodegenerative disease and processes, Dermatology, Infectious Disease, Respiratory, Inflammation and Auto-Immune Disease, Paediatric Cognitive Development & Wound Care, Cardiovascular, Women’s Health, Nutraceutical Product Development, Biomarker Strategies, IVD Clinical Trial Management, Medical Device and Diagnostics Regulatory Medical Writing and Regulatory/Clinical Trial leadership, site feasibility and Clinical Quality Management and Quality Compliance
  • Key role in the creation of milestone Value Proposition product cost and timing RoadMaps for development, regulatory, pre-clinical and clinical trial models
  • Provide multi-functional technical leadership for transitional regulatory submission stages and agency deficiency rescues or management for companies or investors
  • Projects have included cross-functional global Leadership for Due Diligence, Regulatory Strategies and Submissions, Study Design, Protocol Development and Clinical Quality Management, Compliance Design, and Implementation
  • Therapeutic-specific protocol design, global regulatory submissions (US and EU)
  • Specific Biomarker clinical trial sampling collection and statistical models
  • Biomarkers as a Drug Development Tool clinical and regulatory models
  • IVD regulatory strategies development and compliance with EU IVDR
  • Real World Evidence Modelling
  • Consulting CDMO management, QMS, and Work Instructions, audit
  • Hands-on experience leading teams for Sponsors and CROs in pharma drug, biomarker and IVD/medical device product development management, global regulatory affairs management, regulatory medical writing, various functional services, CMC formulation and scale-up oversight, clinical trial design and protocol development, specialized IVD sample collection models, drug development biomarker tool models, specialized IVD central sample clinical trial models and budgets, and quality management including clinical GCP/GLP compliance
  • Human Factors Engineering and Instructions for Use strategies and clinical trial models
  • Senior Compliance Subject Matter Expert including US and EU MDR/IVDR compliance management and hands-on medical writing
  • Product Development, preclinical and Clinical Trial Program management of Design, Budgets, and Management Oversight of cross-functional teams
  • Medical Device Product for development, Design Control, cGMP SOPs, pilot plant to full-scale production
  • Clinical Trial GCP Compliance planning, implementation, audits, CAPA remediation
  • Medical writing management for pharma product development discovery clinical trials, device Technical Documentation File Compilation, CERs, PERs, PMA, 510(k), 505(b)(2), bioequivalence, de novo, white papers, KOL communications and VA document submission preparation
  • Strategy development and FDA interaction for IND, NDA, pre-meetings and follow through for further product development, preclinical and clinical strategies for ophthalmology pharmaceuticals and combination products
  • Led Diagnostics ROC curve verification and validation studies as well as PMPF strategies
  • Contributed to the management of, or lead on ANDA, NDA, INDs, CTAs, IDEs, 505(b)(2), 510(k), de novo and PMA strategies including Combination products and pre-market authorization filings, and other regulatory submissions or Agency Communications such as FDA premeeting, CE mark for Class Is, IIb and III devices and NMPA, KFDA requirements using collaboration
  • I have led SaMD regulatory and development strategies, such as global product registration management
  • COVID-19 EUA, NIOSH and FDA 510(k)s for medical device surgical masks, N95 respirators, antigen detection diagnostics clinical trials, and submissions.
  • Facilitated workshops with clients to identify pain points, establish goals, and define actionable steps towards achieving desired outcomes.
  • Streamlined project management processes, improving efficiency and reducing overall costs.
  • Evaluated clients' needs and created plan of action to provide solutions.
  • Collaborated with internal teams to develop customized solutions that addressed unique client needs.
  • Identified key areas in need of improvement and implemented plans to rectify issues.
  • Prioritized projects and project tasks depending upon key milestones and deadline dates.
  • Increased client satisfaction by providing tailored consulting services and effective problem-solving strategies.
  • Built strong relationships with clients through consistent communication and proactive problem-solving efforts.
  • Presented findings and recommendations to executive-level stakeholders, effectively communicating key insights and action plans.
  • Assessed needs for projects and made proposals to senior executives.
  • Exceeded customer requirements with accurate and deliverable solutions.
  • Developed innovative strategies to address complex business challenges, resulting in increased profitability for clients.
  • Troubleshot issues by understanding and diagnosing root cause and coming up with effective solutions.
  • Mentored junior consultants, helping them enhance their skills and contribute more effectively to projects.
  • Generated reports detailing findings and recommendations.
  • Evaluated client needs and expectations, establishing clear goals for each consulting engagement.
  • Collaborated with cross-functional teams to successfully deliver comprehensive solutions for clients.
  • Developed innovative strategies for clients, resulting in increased revenue and business growth.
  • Led cross-functional teams in execution of strategic projects, fostering collaboration and ensuring alignment with corporate goals.
  • Worked effectively in fast-paced environments.
  • Skilled at working independently and collaboratively in a team environment.
  • Proven ability to learn quickly and adapt to new situations.
  • Excellent communication skills, both verbal and written.
  • Organized and detail-oriented with a strong work ethic.
  • Demonstrated strong organizational and time management skills while managing multiple projects.

Global Lead Regulatory Affairs SME and Manager

Baxter Healthcare International, Medical Products, Therapies
06.2022 - 12.2023
  • Member of multi-BU Baxter Global Regulatory Forum for challenging regulatory questions
  • Collaborates with the Regulatory Affairs Global Business Unit strategists and other cross-functional associates to support EU MDR submission strategies and ongoing SME needs to support CE Mark under EU MDR
  • Provides strategy and tactical input to cross-functional partners (i.e., R&D, Quality, Medical Affairs, Manufacturing, Product Development Owner etc.) driving right first-time submissions for CE Mark and upgrades from MDD to MDR
  • Reviews regulatory content for claims support of promotional material, labeling content, product and process changes, and product documentation
  • Represents Company with EU Notified Bodies Baxter teams including submission and deficiency report support
  • Ensures compliance with and contributes to the optimization of regulatory departmental policies, procedures, and records per applicable regulations and standards
  • Ensures the timely and accurate submission(s) of regulatory documentation, along with suitable and precise responses to deficiencies
  • Coordinates leading cross-functional partners on responses, as necessary
  • Identifies and communicates risks and mitigations associated with regulatory strategies to cross-functional partners including reviews for application of SaMD regulations
  • Provides EU MDR expertise to functional and cross-functional team members including requirements across workstreams for GSPR (i.e., ISO 62366, ISO 10993, Post Market Surveillance, Post-Market Clinical Follow-up Plan and Report, Clinical Evaluation Reports, etc.)
  • Interprets application of standards, regulations, and directives to ensure regulatory compliance
  • Authors impact assessments to external standards as required.

Senior Regulatory Affairs and Compliance Architect & Lead Medical Writer

Wipro, Ltd
09.2018 - 12.2021
  • Lead Global Quality Assurance/Regulatory Affairs, Global CRO Management Services, Clinical and Regulatory Compliance and Quality Assurance global teams
  • Pharmaceutical and Medical Device Clinical Quality Management Planning and execution from Feasibility through site qualification, site audits and training and mid-study compliance review
  • Quality Management Systems reviews, Gap Analysis and remediation, development and SOP development and audits
  • Management of EU MDD to MDR and IVDD to IVDR Regulatory Strategies, Technical Documentation (Technical File) GAP analysis and remediation including reviewing and writing of CER and other pre-CER technical documents for review by regulatory authorities
  • Participated in IVD Classification decisions, UDI traceability, IVD Risk Management Planning and Reports, PMS for IVD leading to PER and PMPF strategies
  • Advisor for IFU harmonization and Post-Market Surveillance Planning and implementation and lead for remediation for Class IIb and Class III devices and Class B-D IVDs
  • Product Lifecycle Management strategies, medical communications, post-market complaint and adverse event management, blogs, and structured regulatory documents for EU, China and US
  • PMA and 510(k) document and section development and writing
  • Work on SaMD regulatory and development strategies with AI and machine learning engineers as part of pilot program with US FDA
  • Global product registration management
  • COVID-19 EUA, NIOSH and FDA 510(k)s for medical device surgical masks, N95 respirators, Diagnostics tests for EUA, 510(k) clinical trials and submission
  • Validation Lead for Data and Analytics program implementation
  • Lead on Validation Plan, CSVR Plan and Validation Report for IQ, OQ, PQ and UAT.

Director of Product Development Program Management

ProPharma Group
07.2016 - 10.2017
  • For Senior Leadership to introduce Program Management of Product Development in pharmaceuticals, biotechnology and personal medicine, medical devices and diagnostics
  • Clinical Compliance, regulatory strategies, program design, budgeting and oversight development of internal strategies, targeted services offerings such as medical writing for risk assessment and CER development, Investigator Brochures, sections of submissions
  • Creation of GCP audit design and compliance with emphasis on biomarkers, preclinical studies design and management, clinical development planning including the Clinical Quality Management Plan
  • Liaison to Professional and Clinical Development Community
  • Writing, Presentations and Publishing relevant articles and blogs.

Principal Strategist, Director level

INC Research, Syneos Health
06.2010 - 05.2013
  • Led Development and Growth of Global Medical Device, Diagnostics and Ophthalmology Group
  • Guided Company Global Ophthalmology, Medical Device and Diagnostics Regulatory Consulting and Submissions Strategies for all regions
  • Collaborated on Drug/Device and device global regulatory and clinical trial management
  • Led group to attain 240% in three years
  • Demonstrated client success and satisfaction
  • Managed cross-functional and cross-therapeutic matrix of responsibilities across functional and multi-therapeutic areas on a global scale for Clinical Trials and Regulatory
  • Global responsibility as resource for all Medical Device, Diagnostics and Drug Delivery Regulatory Strategies and Submissions
  • Supported BD and corporate in the establishment of key relationships in MDDO space
  • Created specialized Medical Device & Diagnostics targeted clinical trial models and budgets and customer tools
  • Managed Large Scale Global Clinical Trials in Ophthalmology Drug Development including Eylea
  • Created specialized biomarker and sample collection models, Initiated and supported development of Risk Based Monitoring Model including selective approaches to SDV sampling and mix of on-site and central monitoring and data management
  • Developed clinical trial study and budget models for Diagnostics Verification (ROC curves) and Validation for diagnostic and predictive outcomes
  • Co-developed Medical Device Post-Approval model for Feasibility, Risk Analysis, Action Plans and protocol development targeting both post-market surveillance requirements and evidence-based reimbursement or marketing studies as one arm or comparative study design
  • Created novel Human Factors Engineering and Instructions for Use clinical trial models.

Chief Science Officer

Corneal Science Corporation A CDMO
01.2001 - 05.2010
  • Leadership of growth-oriented small ophthalmic pharmaceutical and medical device development, manufacturing, and distribution company
  • Successful leadership of ophthalmic OTC and Rx drug development program for own product and contract formulation and manufacturing of private label or contracted ophthalmic liquid Rx and OTC products as CDMO
  • Supervision of all functions: product development, global regulatory strategies and execution, aseptic manufacturing scale up, and cGMP including QMS, complaints, compliance, and commercialization
  • Responsibilities included Product Development, Formulation and Process Development, Strategic Business Planning, Budgets, P&L, Balance Sheet and Cash Flow reviews, funding requirement review and staff performance review model and action plans
  • Led team for development of drug formulation and aseptic manufacturing processes for liquid topicals and ear products
  • Co-developed first IVD using tears as the bodily fluid testing for proteins and antibodies
  • First approved FDA submission and CLIA reimbursement for ophthalmology IVDs
  • Prior Company as Chief Science Officer and investor led the Development of the first approved soft lens with permanent colorant resulting in creation of new segment.

Education

Doctor of Optometry -

Indiana University

Bachelor of Arts - Psychology

University of Iowa

Skills

  • Regulatory/Clinical Development
  • Strategic Reg/Clinical/Compliance Roadmap
  • Milestone Value Proposition Analytics & Build
  • Start-up and emerging growth experience
  • Multi-national and Entrepreneurial Experience
  • Therapeutic Program Management
  • Quality Management Leadership
  • IVD and Diagnostics Project Management
  • MDR/IVDR Technical File Development
  • GAP analysis and CER/PER
  • Regulatory Medical Writing
  • Clinical Quality Management Planning
  • Site ID, Feasibility, Qualification
  • Product Development and Innovation
  • Quality Assurance QMS/Harmonization
  • Strategic Planning Technical to Business
  • Product Development Leadership
  • Regulatory Compliance
  • GxP Compliance
  • Project Management
  • Risk Management
  • Collaborative Problem-solving abilities
  • Effective Communicator

Publications

  • Ocular Surface Disease: The Inflammatory / Oxidative Stress Cascade
  • Tear Chemistry and Presbyopia – Impact on Dry Eye and Contact Lenses
  • International Regulatory Pathways for Medical Devices: Understanding Changing Landscape to Develop Go-to-Market Strategies
  • Latin American Medical Device and Diagnostics International Strategies
  • Medical device clinical trials in China - The Real World - A strategic regulatory and clinical trial model
  • Diagnostic Biomarker Verification and Validation Clinical Trial Adaptive Design Models for Speed to Market Strategies
  • The Real World of Clinical Trials for Medical Devices in China – a strategic regulatory and clinical trial approach
  • Device Drug Delivery Future Directions and Developments
  • 21st Century Cures Act – A Major legislative action by Congress affecting the FDA and Industry – Part I
  • 21st Century Cures Act – A Major legislative action by Congress affecting the FDA and Industry – Part II
  • 21st Century Cures Act – Impact of the Drug Development Tool and Other Clinical Considerations
  • Clinical Trial Good Clinical Practice (GCP) – Are You Ready?
  • Five Ways Sites Can Prepare for Implementation of the 21st Century Cures Act
  • Good Clinical Practice (GCP) Clinical Trial Audit of Personalized Medicine Site and CAPA Implementation – A Case Study
  • EU MDR Global Remediation – An Aesthetic Device Case Study
  • EU MDR QMS Remediation – A global harmonization Case Study
  • Responding to Coronavirus Ventilator Shortage, A directional review

Timeline

Principal & Senior Consulting SME

624Advisors
01.2024 - Current

Global Lead Regulatory Affairs SME and Manager

Baxter Healthcare International, Medical Products, Therapies
06.2022 - 12.2023

Senior Regulatory Affairs and Compliance Architect & Lead Medical Writer

Wipro, Ltd
09.2018 - 12.2021

Director of Product Development Program Management

ProPharma Group
07.2016 - 10.2017

624Advisors Founder, Principal Senior SME

624Advisors/Avodex Partners
05.2013 - Current

Principal Strategist, Director level

INC Research, Syneos Health
06.2010 - 05.2013

Chief Science Officer

Corneal Science Corporation A CDMO
01.2001 - 05.2010

Bachelor of Arts - Psychology

University of Iowa

Doctor of Optometry -

Indiana University
Dr Alan Touch